Abstract：OBJECTIVE To analyze the clinical intervention and treatment of drug-induced hypersensitivity syndrome (DIHS) in maternal. METHODS Clinical pharmacists and physicians jointly participated in the treatment of a highly suspected DIHS puerpera. RESULTS A 32-year-old parturient was treated with piperacillin sulbactam after cesarean section; the symptoms were relieved after treatment and discharged. CONCLUSION In clinical work, we should improve our understanding of DIHS, achieve early recognition and treatment, to minimize the mortality and improve the prognosis of patients.
RICARDO C P, JARDIM C R F. Drug reaction with eosinophilia and systemic symptoms (DRESS)/Drug-induced hypersensitivity syndrome (DIHS): a review of current concepts [J]. An Bras Dermatol, 2012, 87(3):435-449.
[2]
GUGLIELMO B, MARIA T, IVAN G. Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review [J]. BMC Infect Dis, 2010, 10(1):1-5.
[3]
KIM S H, YE Y M, PALIKHE N S, et al. Genetic and ethnic risk factors associated with drug hypersensitivity [J]. Curr Opin Allergy Clin Immunol, 2010, 10(4): 280-290.
[4]
SKOWRON F, BENSAID B, BALME B, el al. Drug reaction with eosinophilia and systemic symptoms(DRESS): clinicopa -thological study of 45 cases[J]. J Eur Acad Dermatol Venereol, 2015, 29(11):2199-2205.
[5]
HUSAIN Z, REDDY B Y, SCHWARTZ R A. DRESS syndrome: Part I. Clinical perspectives[J]. J Am Acad Dernatol, 2013, 68(5): 693.e1-e14.
[6]
SCHNYDER B, BROCKOW K. Pathogenesis of drug allergycurrent concepts and recent insights [J]. Clin Exp Allergy,2015, 45(9): 1376-1383.
[7]
PAVLOS R, MALLAL S, OSTROV D, et al. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy [J]. J Allergy Clin Immunol Pract, 2014, 2(1):21-33.
[8]
CHINESE JOURNAL OF DRUG EVALUATION. Drug hypersensitivity syndrome of piperacillin in Canada[J]. Chin J Drug Eval(中国药物评价),2016, 27(2):69.
[9]
WORKING GROUP ON REVISION OF GUIDING PRINCIPLES FOR CLINICAL APPLICATION OF ANTIBIOTICS. Guidelines for Clinical Use of Antibacterials(抗菌药物临床应用指导原则)[M]. 2015 Ed. Beijing: People's Medical Publishing House, 2015:7.
[10]
HUSAIN Z, REDDY B Y, SCHWARTZ R A. DRESS syndrome: part Ⅰ. Clinical perspectives[J]. J Am Acad Dermatol, 2013,68(5):693.el-e14.
[11]
WANG L, MEI X L. Drug reaction with eosinophilia and systemic symptoms: retrospective analysis of 104 cases over one decade [J]. Chin Med J (Engl), 2017, 130(8):943-949.
[12]
WALSH S A, CREAMER D. Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking [J]. Clin Exp Dermatol, 2011,36(1):6-11.
[13]
KARDAUN S H, SIDOROFF A,V ALEYRIE-ALLANORE L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? [J]. Br J Dermatol, 2007, 156 (3):609-611.
[14]
ALLERGENIC DISEASE COMMITTEE OF DERMATOLOGIST BRANCH, CHINESE MEDICAL DOCTOR ASSOCIATION. Expert consensus on diagnosis and treatment of drug hypersensitivity syndrome[J]. Chin J Dermatol(中华皮肤科杂志), 2018, 51(11):787-790.
[15]
SKOWRON F, BENSAID B, BALME B, et al. Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopa-thological study of 45 cases[J]. J Eur Acad Dermatol Venereol, 2015,29(11):2199-2205.
[16]
SHIOHARA T, KANO Y. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management [J]. Expert Opin Drug Saf, 2017,16(2):139-147.
[17]
HUSAIN Z, REDDY B Y, SCHWARTZ R A. DRESS syndrome: part Ⅱ. Management and therapeutics[J]. J Am Acad Dermatol, 2013, 68(5):709.e1-e9.
[18]
FUNCK-BRENTANO E, DUONG T A, BOUVRESSE S, et al. Therapeutic management of DRESS: a retrospective study of 38 cases [J]. J Am Acad Dermatol, 2015,72 (2):246-252.
2021, Vol. 56 
